At The Yost Legal Group, we have extensive experience standing up to major pharmaceutical manufacturers. We are currently representing young men and boys who were harmed by Johnson & Johnson by using the medication Risperdal which was supposed to make their lives more manageable. Instead, they are now forced to deal with the embarrassing symptoms of the Risperdal side effect gynecomastia, which causes enlarged breasts, tenderness and sensitivity, and nipple discharge.
One of our clients, who we will call John, was prescribed Risperdal at age 10 to help manage his attention-deficit/hyperactivity disorder (ADHD), attention deficit disorder (ADD), and oppositional defiant disorder. He was diagnosed with gynecomastia less than one year later. His breast tissue is swollen due to stimulation of his pituitary gland by Risperdal. This caused excess production of a hormone called prolactin, which contributes to female breast development. He suffers from increased breast pain, sensitivity, and nipple discharge. John should be spending his summer outside playing and swimming with friends. Instead, he remains isolated in his house due to discomfort and embarrassment.
Another client, who we will call Kevin, took Risperdal at the age of 10 for two years to treat his ADHD and pervasive developmental disorder not otherwise specified (PDD-NOS). Kevin, now 19 years old, suffers from gynecomastia. His breasts are enlarged which negatively impacts his self-esteem. He has developed depression and now suffers from new psychological issues, in addition to his underlying behavioral problems. Kevin’s mother describes her son’s experience as “truly awful” and just wants justice for her son.
If you or a loved one has experienced male breast growth or has been diagnosed with gynecomastia after use of the psychotropic drug Risperdal, call The Yost Legal Group at 1-800-YOST-LAW (967-8529) for a FREE, confidential consultation. At The Yost Legal Group, there is no fee or expense unless you recover.
*Names of clients have been changed to protect their identities*